Active, not recruitingPHASE1, PHASE2NCT04758533

Clinical Trial to Assess the Safety and Efficacy of AloCELYVIR With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) in Combination With Radiotherapy or Medulloblastoma in Monotherapy

Studying Diffuse intrinsic pontine glioma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Hospital Infantil Universitario Niño Jesús, Madrid, Spain
Principal Investigator
Álvaro Lassaletta Atienza, MD
Hospital Infantil Universitario Niño Jesús
Intervention
AloCELYVIR(biological)
Enrollment
13 enrolled
Eligibility
1-21 years · All sexes
Timeline
2021 – 2026

Study locations (1)

Collaborators

Apices Soluciones S.L.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04758533 on ClinicalTrials.gov

Other trials for Diffuse intrinsic pontine glioma

Additional recruiting or active studies for the same condition.

See all trials for Diffuse intrinsic pontine glioma →

← Back to all trials